Tetra-cyclic carboline derivatives for inhibiting angiogenesis

Details for Australian Patent Application No. 2005222627 (hide)

Owner PTC Therapeutics, Inc.

Inventors Qi, Hongyan; Choi, Soongyu; Moon, Young-Choon; Lennox, William Joseph; Corson, Donald Thomas; Tamilarasu, Nadarajan; Cao, Liangxian

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-A-2005222627

PCT Pub. Number WO2005/089752

Priority 60/552,724 15.03.04 US

Filing date 15 March 2005

Wipo publication date 29 September 2005

International Classifications

A61K 31/4166 (2006.01)

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089752 Priority application(s): WO2005/089752

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222628-Pet food compositions containing an added boron source

2005222626-A method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis